Zepp Health Corp. · NYSE:ZEPP

Zepp Health — Q3 2025 Earnings Presentation

11 slides from Zepp Health's earnings presentation, Nov 4, 2025

  1. Slide 1: Zepp Health Earnings Presentation Third Quarter 2025

    Zepp Health Earnings Presentation Third Quarter 2025 Investor Relations 4 November 2025

  2. Slide 2: Table of Contents

    Table of Contents 01 3Q25 Financial and Operating Results 05 Adjusted Operating Expenses 02 Revenue 06 Net Income/ Earnings Performance 03 3Q25 Gross Margin 07 Liquidity Position 04 3Q25 Revenue and Gross Margin Trend 08 Business Outlook 2 Empowering Health, Inspiring Joy

  3. Slide 3: 3Q25 Financial and Operating Results

    3Q25 Financial and Operating Results Revenue • Meeting upper end of guidance Adjusted Net • Attributable to Zepp ** range Loss $75.8 -$0.7 Million Million Units Shipped 0.8 Million 3Q24 0.7 Million Xiaomi Amazfit-branded 0.0 3Q24 0.8 3Q24 Million 0.2 Million Million 0.5 Million Currency: USD **Adjus

  4. Slide 4: Revenue

    Revenue US$ million US$ million +41.2% 174 +78.5% 76 123 61.4% 61.4% 46.5% 10 46.5% 42 8.2% 1 (67.3%) 174 (67.3%) 76 3.8% 38.6% 53.5% 38.6% 113 53.5% 100.0% (32.7%) $354.660.6% 100.0% 100.0% (32.7%) (67.3%) $354.6 60.6% 41 100.0% 65.5% 91.8% 65.5% (32.7%) (32.7%) 96.2% 94.0% $260.6 3Q24 3Q25 9M24 9M

  5. Slide 5: 3Q25 Gross Margin

    3Q25 Gross Margin Gross Profit (USD in Millions） Gross margin As % of sales 40.6% 40.8% 38.2% 38.2% 28.9 17.2 (67.3%) 0.5 28.9 16.7 (32.7%) 3Q24 3Q25 Xiaomi wearable products 3Q24 3Q25 3Q24 3Q25 Amazfit-branded wearable products Amazfit-branded Total 5 Empowering Health, Inspiring Joy

  6. Slide 6: 3Q25 Revenue and Gross Margin Trend

    3Q25 Revenue and Gross margin trend Revenue(USD in Millions) Gross Margin (USD in Millions) & Gross Margin % 100 $94 $92 Between 40.0 50.0% $82 $82-86m $83 9% $76 40.6% 21% 32% $30 38.2% 40.0% 39% 30.0 40.3% 37.3% $28 34.7% $29 33.9% 36.8% 36.8% 36.2% $60 $59 2% 30.0% $22 $22 50 $20 20.0 22.0% $41 $

  7. Slide 7: Adjusted Operating Expenses

    Adjusted Operating Expenses Adjusted operating expenses Adjusted operating expenses as a % of total revenue (USD in Millions） 90 100% 90% 75 80% 32 32 70% 60 60% 25.6% 45 50% 38 40% 18.4% 33 30 30% 26.5% 20% 21.7% 15 17 17 10% 13.3% 9.7% - 0% 9M24 9M25 9M24 9M25 G&A S&M R&D G&A S&M R&D 7 Empowering

  8. Slide 8: Net Income/ Earnings Performance

    Net Income/ Earnings Performance Net Income (loss) Attributable to Zepp Adjusted Net Income (loss) Attributable to Zepp (USD in Millions） (USD in Millions） 0.0 -1.6 0.0 -0.7 -10.0 -10.0 -13.3 -11.8 -20.0 -20.0 -30.0 -30.0 -25.0 -29.1 -34.2 -40.0 -38.9 -40.0 3Q24 3Q25 9M24 9M25 3Q24 3Q25 9M24 9M25 3Q

  9. Slide 9: Liquidity Position

    Liquidity Position Liquidity Position Cash and Cash Equivalents (USD in Millions） 400.0 Share Repurchase Program • Until 2025/09/30 - US$16.1 million 200.0 141.4 141.1 145.8 146.7 140.5 134.5 132.3 128.7 127.7 110.7 103.8 102.6 95.3 - 2022.09.30 2022.12.31 2023.03.31 2023.06.30 2023.09.30 2023.12.31

  10. Slide 10: Business Outlook

    Business Outlook 1 2 3 4 5 • International • Expanding Product • New Product • Growing Value- • Strict Cost Control Expansion Categories Releases Added Service Revenue For the fourth quarter of 2025, the Company currently expects: • Net revenues to be between USD82 million and USD86 million. 10 Empo

  11. Slide 11: Thank You!

    Thank You! © 2022 Zepp Health Corporation. All Rights Reserved.

Zepp Health — Q3 2025 Earnings Presentation on 6ix